Background

MSCANOrthopedic devices are increasingly used for treatment of the degenerative joint disease and for fixation of bone fractures in the growing population of the elderly. The incidence of PJI is ranging from 0.5-2.5% for primary interventions and up to 20% for revision procedures. In addition, hematogenous PJI can occur at any time after implantation and the risk of infection remains during the entire prosthesis indwelling time. Prosthetic joint infection is associated with significant morbidity and costs to the healthcare system.

Orthopedic prostheses are increasingly used in the growing population of the elderly, mainly for treatment of the degenerative joint disease and bone fractures. Prosthetic joint infections (PJI) are associated with significant morbidity and costs to the healthcare system. Evidence for optimal management of PJI with best outcome and lowest expenses is limited and recommendations between countries vary significantly. There is unmet need to standardized diagnostic procedures and definition of infection as well as achieve a consensus for uniform treatment guidelines.